SCOPE Study

Overview

About this study

The purpose of this study will prospectively compare visual satisfaction and ease of use between corneal gas permeable and scleral lenses for patients with mild to moderate keratoconus who are naiive to lens use. 

Keratoconus is a non-inflammatory condition in which the cornea or clear front surface of the eye steepens and thins and can decrease vision. It is a progressive disease in which corneal irregularity increases and thickness decreases.  The patient-reported quality of life mayvary depending upon the prescribed form of contact lens correction.. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age 18 or older.
  • Diagnosis of keratoconus.
  • Available baseline corneal topography and pachymetry.
  • Amsler-Krumeich keratoconus classification of stage 1 or higher.

Exclusion Criteria:

  • No prior corneal transplantation or INTACTS.
  • No prior use of hybrid, corneal or scleral gas permeable lenses.
  • Presence of corneal scarring.

Eligibility last updated 9/17/21. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Muriel Schornack, O.D.

Open for enrollment

Contact information:

Emily Treichel

(507) 284-8558

Treichel.Emily@mayo.edu

More information

Publications

Publications are currently not available